BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1310586)

  • 1. Treatment of cytomegalovirus retinitis--1992.
    Jabs DA
    Arch Ophthalmol; 1992 Feb; 110(2):185-7. PubMed ID: 1310586
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of CMV retinitis.
    Morris DJ
    Lancet; 1992 Jan; 339(8787):247. PubMed ID: 1346202
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
    Nelson MR; Barter G; Hawkins D; Gazzard BG
    Lancet; 1991 Jul; 338(8761):250. PubMed ID: 1676798
    [No Abstract]   [Full Text] [Related]  

  • 4. Seeing the way forward for treatment of CMV retinitis.
    Lancet; 1991 Dec; 338(8781):1494-5. PubMed ID: 1683924
    [No Abstract]   [Full Text] [Related]  

  • 5. Why was treatment of cytomegalovirus retinitis randomized?
    Salit IE
    Ann Intern Med; 1992 Apr; 116(7):604-5. PubMed ID: 1311907
    [No Abstract]   [Full Text] [Related]  

  • 6. National Eye Institute issues clinical alert about CMV retinitis in AIDS.
    Marwick C
    JAMA; 1991 Nov; 266(19):2665. PubMed ID: 1658405
    [No Abstract]   [Full Text] [Related]  

  • 7. Foscarnet.
    Med Lett Drugs Ther; 1992 Jan; 34(861):3-4. PubMed ID: 1309469
    [No Abstract]   [Full Text] [Related]  

  • 8. Foscarnet for CMV retinitis.
    Wood CA
    Lancet; 1992 Feb; 339(8791):501. PubMed ID: 1346861
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
    Farese RV; Schambelan M; Hollander H; Stringari S; Jacobson MA
    Ann Intern Med; 1990 Jun; 112(12):955-6. PubMed ID: 2160217
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS file.
    Am J Nurs; 1991 Oct; 91(10):17. PubMed ID: 1654745
    [No Abstract]   [Full Text] [Related]  

  • 11. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1991 Dec; 266(23):3263. PubMed ID: 1660082
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of CMV retinitis.
    Bachman DM
    N Engl J Med; 1992 Jun; 326(25):1702; author reply 1702-3. PubMed ID: 1317012
    [No Abstract]   [Full Text] [Related]  

  • 13. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of cytomegalovirus in AIDS--more than meets the eye.
    Hirsch MS
    N Engl J Med; 1992 Jan; 326(4):264-6. PubMed ID: 1309391
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of CMV retinitis.
    Deray G; Katlama C; Jacobs C
    N Engl J Med; 1992 Jun; 326(25):1702. PubMed ID: 1317011
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet.
    Jacobson MA
    Am J Med; 1992 Feb; 92(2A):26S-29S. PubMed ID: 1310573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of CMV retinitis.
    Skolnik PR
    N Engl J Med; 1992 Jun; 326(25):1701; author reply 1702-3. PubMed ID: 1317010
    [No Abstract]   [Full Text] [Related]  

  • 18. Foscarnet approved for cytomegalovirus retinitis.
    Am Fam Physician; 1991 Nov; 44(5):1890. PubMed ID: 1659165
    [No Abstract]   [Full Text] [Related]  

  • 19. Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
    Polis MA
    Am J Med; 1992 Feb; 92(2A):22S-25S. PubMed ID: 1310572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison.
    Moyle G; Harman C; Mitchell S; Mathalone B; Gazzard BG
    J Infect; 1992 Jul; 25(1):21-7. PubMed ID: 1326012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.